This annual report outlines the National Blood Authority’s performance and achievements in the financial year ending 30 June 2009. It also incorporates the National Blood Authority Board report for the same period, as required under section 44(2) of the National Blood Authority Act 2003.
The annual report was prepared in accordance with the Department of the Prime Minister and Cabinet’s requirements for annual reports and was written to inform stakeholders, including government and the community, of the ways in which the roles and responsibilities of the NBA have been implemented.
The report is divided into seven parts:
Part One provides a summary explanation of the NBA’s key activities and outlines our major achievements as well as issues and challenges faced during 2008–09. It consists of the NBA General Manager’s review, a report from the Chair of the NBA Board, biographies of our board members, a report from our new Principal Medical Officer, and an overview of the Australian blood sector.
Part Two reports on performance against the NBA’s Operational Plan 2008–09. It provides an analysis of the NBA’s performance against the Agency Outcomes and Output Groups within the Health and Ageing Portfolio Budget Statements 2008–09 and describes the NBA’s achievements during the year.
Part Three describes external influences that could affect the way that the NBA does business in the future. It describes 2008–09 changes to our external environment, identifies factors that may affect global supply, demand and pricing, and notes a range of international trends in regulatory and blood-related clinical practice.
Part Four describes various aspects of how we manage our affairs. It includes information on corporate governance, planning and service delivery, and people management. It also describes our audit arrangements and how we manage risk and fraud. Information is also provided on our budget and financial management arrangements.
Part Five specifies how the NBA complies with a range of external policies. Among the subjects covered are disability, occupational health and safety, productivity gains, ecologically sustainable development, and freedom of information.
Part Six presents the NBA’s financial statements for the year ending 30 June 2009.
The appendices contain the objectives of governments detailed in the National Blood Agreement, the NBA’s Resource Statement, lists of fresh blood components and plasma-derived and recombinant plasma products supplied under contract, further details of fresh blood component supply distribution across Australia, a list of acronyms and an index.